HRGN Statistics
Total Valuation
Harvard Apparatus Regenerative Technology has a market cap or net worth of 45.35 million. The enterprise value is 42.08 million.
| Market Cap | 45.35M |
| Enterprise Value | 42.08M |
Important Dates
The next estimated earnings date is Monday, March 24, 2025.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Harvard Apparatus Regenerative Technology has 15.92 million shares outstanding. The number of shares has increased by 10.62% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.92M |
| Shares Change (YoY) | +10.62% |
| Shares Change (QoQ) | +5.32% |
| Owned by Insiders (%) | 42.75% |
| Owned by Institutions (%) | n/a |
| Float | 6.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 173.24 |
| PB Ratio | 11.81 |
| P/TBV Ratio | 11.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.12 |
| EV / Sales | 179.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.19 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -207.81 |
Financial Efficiency
Return on equity (ROE) is -250.58% and return on invested capital (ROIC) is -137.54%.
| Return on Equity (ROE) | -250.58% |
| Return on Assets (ROA) | -105.70% |
| Return on Capital (ROIC) | -137.54% |
| Revenue Per Employee | 13,056 |
| Profits Per Employee | -456,333 |
| Employee Count | 18 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.00% in the last 52 weeks. The beta is -1.22, so Harvard Apparatus Regenerative Technology's price volatility has been lower than the market average.
| Beta (5Y) | -1.22 |
| 52-Week Price Change | -34.00% |
| 50-Day Moving Average | 3.17 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 45.27 |
| Average Volume (20 Days) | 528 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, Harvard Apparatus Regenerative Technology had revenue of 235,000 and -8.21 million in losses. Loss per share was -0.57.
| Revenue | 235,000 |
| Gross Profit | 129,000 |
| Operating Income | -7.69M |
| Pretax Income | -8.21M |
| Net Income | -8.21M |
| EBITDA | -7.67M |
| EBIT | -7.69M |
| Loss Per Share | -0.57 |
Balance Sheet
The company has 3.59 million in cash and 329,000 in debt, giving a net cash position of 3.26 million or 0.21 per share.
| Cash & Cash Equivalents | 3.59M |
| Total Debt | 329,000 |
| Net Cash | 3.26M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 3.84M |
| Book Value Per Share | 0.24 |
| Working Capital | 2.73M |
Cash Flow
| Operating Cash Flow | -4.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 54.89% |
| Operating Margin | -3,271.91% |
| Pretax Margin | -3,495.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Harvard Apparatus Regenerative Technology does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.62% |
| Shareholder Yield | -10.62% |
| Earnings Yield | -20.18% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 22, 2017. It was a reverse split with a ratio of 0.05.
| Last Split Date | Dec 22, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Harvard Apparatus Regenerative Technology has an Altman Z-Score of -6.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.81 |
| Piotroski F-Score | n/a |